Join the Plaque Psoriasis group to help and get support from people like you.
Plaque Psoriasis News
Obese Kids May Face Higher Odds for Eczema, Psoriasis
WEDNESDAY, Aug. 21, 2024 – Obese kids are more likely to develop immune-based skin problems like eczema or psoriasis, a new study says. Analysis of more than 2.1 million Korean children between 2009...
Racial Differences Identified in Frequency of Biopsy for Psoriasis
FRIDAY, Aug. 9, 2024 – There are racial differences in the frequency of skin biopsy for psoriasis, indicating diagnostic uncertainty, according to a research letter published online Aug. 7 in JAMA...
Psoriasis, Psoriatic Arthritis Tied to Higher Risk of Polyneuropathy
MONDAY, July 29, 2024 – Psoriasis and psoriatic arthritis may be associated with an increased risk of polyneuropathy, according to a study published online June 28 in Muscle & Nerve. Pietro E. ...
Air Pollution Exposure Tied to New Psoriasis
THURSDAY, July 18, 2024 – Long-term exposure to air pollution is associated with the development of new psoriasis, according to a study published online July 16 in JAMA Network Open. Junhui Wu, ...
Psoriasis, With or Without Psoriatic Arthritis, Associated With Fatigue
MONDAY, July 1, 2024 – Psoriasis is associated with fatigue, especially among those with psoriatic arthritis (PsA), according to a study published in the July issue of the Journal of the American...
Coexistence of Psoriatic Arthritis, Atopic Dermatitis May Offer Treatment Insights
MONDAY, May 13, 2024 – Psoriatic arthritis (PsA) and atopic dermatitis (AD) can coexist, and the presence of both conditions may mean special attention should be given to selecting optimal...
Tobacco Smoking Reduces the Odds of Psoriasis Improvement
WEDNESDAY, April 24, 2024 – Tobacco smoking is negatively associated with resolution of psoriasis symptoms, according to a study published in the April issue of Tobacco Induced Diseases. Yan Qiang,...
FDA Approves Selarsdi (ustekinumab-aekn), a Biosimilar to Stelara
REYKJAVIK, Iceland & PARSIPPANY, N.J.--(BUSINESS WIRE) April 16, 2024 --Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE:...
Mouse Study Yields Clues to Why Psoriasis Worsens
MONDAY, March 25, 2024 – Australian researchers say they have identified a gene mutation that causes the skin disease psoriasis. A chronic inflammatory condition, psoriasis causes red, scaly, itchy...
AAD: Bimekizumab Response Durable at Four Years for Moderate-to-Severe Psoriasis
FRIDAY, March 15, 2024 -- Patients with psoriasis treated with bimekizumab rapidly achieve high levels of clinical and health-related quality-of-life responses that are durable at four years, ...
FDA Approves Simlandi (adalimumab-ryvk), an Interchangeable Biosimilar to Humira
REYKJAVIK, Iceland and PARSIPPANY, N.J., Feb. 24, 2024 (GLOBE NEWSWIRE) – Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE:...
Deep Learning Improves Diagnostic Accuracy for Skin Diseases
FRIDAY, Feb. 16, 2024 – Deep learning-aided decision support improves diagnostic accuracy for skin disease, according to a study published online Feb. 5 in Nature Medicine. Matthew Groh, Ph.D., from...
JNJ-77242113 Shows Greater Efficacy Than Placebo for Plaque Psoriasis
THURSDAY, Feb. 8, 2024 – For patients with moderate-to-severe plaque psoriasis, the interleukin-23-receptor antagonist peptide JNJ-77242113 shows greater efficacy than placebo, according to a study...
Biological Agent Trials for Psoriasis Rarely Include Patient Images
FRIDAY, Dec. 29, 2023 – Few randomized controlled trials involving biological agents for psoriasis treatment include patient images, according to a review published online Nov. 15 in the Journal of...
Skin Conditions Flare Up When Wildfires Nearby
TUESDAY, Dec. 26, 2023 – The smoke billowing from this summer’s devastating wildfires wasn’t just bad for your lungs. Skin problems also seem to worsen, with dermatology visits rising as air quality ...
Further information
Related condition support groups
Related drug support groups
methylprednisolone, Humira, Enbrel, Remicade, Otezla, Stelara, Cosentyx, Skyrizi, dexamethasone, adalimumab, etanercept, halobetasol, Taltz